Elanco Animal Health Supports Poultry Vets to Optimise IBD Vaccination07 April 2016
US - Elanco Animal Health has sponsored the webinar “Optimising protection against Infectious Bursal Disease (IBD) with Live Attenuated Vaccines“ as part of the educational program “Revise, Try, Change”.
Dr Sjaak de Wit from GD Deventer conducted on 2nd March the live presentation that can be viewed here.
During the lecture, Dr de Wit emphasised the role of live attenuated vaccines as an effective, long-established and widely used vaccination strategy to ensure a proper IBD control.
An early protection to the birds was identified as a key factor to select a field vaccination program while several studies shown the early onset of immunity induced by LC-75 vaccine strain (AviPro® Precise).
Elanco supports poultry producers and veterinarians on IBD control with an experienced field technical team and AviPro® Precise, an intermediate IBD vaccine, and AviPro® IBD Xtreme which is an intermediate plus IBD vaccine.
Not all products are available in all geographies. For more information please consult your local Elanco representative and visit revise-try-change.com.
Elanco provides comprehensive products and knowledge services to improve animal health and food animal production in more than 70 countries around the world.
We value innovation, both in scientific research and daily operations, and strive to cultivate a collaborative work environment for nearly 7,000 employees worldwide.
Together with our customers, we are committed to raising awareness about global food security, and celebrating and supporting the human-animal bond.
Founded in 1954, Elanco is a division of Eli Lilly and Company. Our worldwide headquarters and research facilities are located in Greenfield, Indiana. Visit us at Elanco.com.